Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Minerva Neurosciences, Inc - Common Stock
(NQ:
NERV
)
2.160
+0.020 (+0.93%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Minerva Neurosciences, Inc - Common Stock
< Previous
1
2
3
4
5
6
Next >
Minerva Neurosciences Reports Third Quarter 2022 Financial Results and Business Updates
November 09, 2022
Company To Host Live Webcast Today at 8:30 a.m. ET
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 09, 2022
Gainers Merrimack Pharmaceuticals (NASDAQ:MACK) shares rose 180.0% to $11.2 during Wednesday's pre-market session. The company's market cap stands at $150.1 million. As per the news, the Q3 earnings...
Via
Benzinga
Minerva Neurosciences to Report Third Quarter 2022 Financial Results and Business Updates on November 9, 2022
November 02, 2022
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
Minerva Neurosciences Shares Sink On Regulatory Setback For Schizophrenia Candidate
October 17, 2022
Via
Benzinga
Why IBM Shares Are Trading Higher; Here Are 21 Stocks Moving Premarket
October 20, 2022
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) rose 20.9% to $0.1063 in pre-market trading after dipping 26% on Wednesday. COMSovereign recently announced receipt of Nasdaq listing determination.
Via
Benzinga
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
October 18, 2022
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
Via
Benzinga
Dow Rises Over 2%; S&P 500 Up 100 Points
October 17, 2022
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 300 points on Monday.
Via
Benzinga
Virgin Orbit And 4 More Short Squeeze Stocks That Could Soar This Week — Including A Stock Moving Up 968 Positions
October 17, 2022
Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 17, 2022
Gainers
Via
Benzinga
Nasdaq Jumps 300 Points; Bank of America Tops Q3 Estimates
October 17, 2022
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 300 points on Monday.
Via
Benzinga
Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday's Mid-Day Session
October 17, 2022
Gainers FedNat Holding Company (NASDAQ: FNHC) shares rose 78.9% to $0.93 after jumping 48% on Friday.
Via
Benzinga
GLSI, AVTE: The Top 5 Short Squeeze Stocks to Watch This Week
October 17, 2022
Short-squeeze stocks continue to be a big deal for speculative traders and we're helping them out with a list to keep in mind this week!
Via
InvestorPlace
Looking Into Minerva Neurosciences's Recent Short Interest
October 17, 2022
Minerva Neurosciences's (NASDAQ:NERV) short percent of float has fallen 47.4% since its last report. The company recently reported that it has 573 thousand shares sold short, which is 14.49% of all...
Via
Benzinga
US Stocks Open Higher; Dow Surges 500 Points
October 17, 2022
U.S. stocks traded higher this morning, with the Dow Jones gaining around 500 points on Monday.
Via
Benzinga
Minerva Neurosciences Receives Refusal to File Letter from FDA for its New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
October 17, 2022
From
Minerva Neurosciences, Inc
Via
GlobeNewswire
TOP Ships, Weber And 3 More Short Squeeze Stocks That Could Soar This Week
October 10, 2022
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates based on the...
Via
Benzinga
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
October 12, 2022
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.
Via
Benzinga
TOPS, SURG: The Top 5 Short Squeeze Stocks This Week
October 10, 2022
Short squeeze stocks are still popular with speculative traders and that has us going over the top ones to keep an eye on this week!
Via
InvestorPlace
How Is The Market Feeling About Minerva Neurosciences?
September 28, 2022
Minerva Neurosciences's (NASDAQ:NERV) short percent of float has fallen 31.87% since its last report. The company recently reported that it has 1.09 million shares sold short, which is 27.55% of all...
Via
Benzinga
10 Short Squeeze Candidates That May Soar: Minerva Neurosciences, FaZe, Getty Images And More
September 26, 2022
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move.
Via
Benzinga
NERV, FAZE: The Top 5 Short Squeeze Stocks This Week
September 26, 2022
Short squeeze stocks are still worth tracking as traders look for potential gains this week and we've got a list of potential targets!
Via
InvestorPlace
NRBO, FAZE: The Top 5 Short Squeeze Stocks to Watch This Week
September 19, 2022
Traders continue to show interest in short squeeze stocks this week as they seek out likely targets that will run higher.
Via
InvestorPlace
5 Short Squeeze Stocks That Could Soar: NeruoBo Pharmaceuticals, FaZe Holdings And More
September 19, 2022
Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge move. Here’s a look at the top five short squeeze candidates for the week...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 14, 2022
Gainers Enochian BioSciences (NASDAQ:ENOB) shares moved upwards by 27.8% to $2.3 during Wednesday's after-market session. The market value of their outstanding shares is at $121.7 million.
Via
Benzinga
Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday
September 01, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
August 31, 2022
Via
Benzinga
Short Interest Sector Focus: Healthcare Sector
August 30, 2022
As of the close of business on Monday, 8/29, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 29, 2022
Via
Benzinga
Dow, Nasdaq Off Triple Digits As Market Rout Deepens
August 29, 2022
The selloff among stocks is deepening as Fed Chairman's jarring Jackson Hole speech continues to send waves through Wall Street.
Via
Talk Markets
Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday
August 30, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.